We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+26.39%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$133B
AUM Growth
+$15.7B
(+13%)
Cap. Flow
-$1.75B
Cap. Flow
% of AUM
-1.32%
Top 10 Holdings %
Top 10 Hldgs %
30.35%
Holding
4,370
New
224
Increased
1,883
Reduced
1,827
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$117M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$117M |
| 3 |
SPCX
SpaceX
SPCX
|
+$100M |
| 4 |
P
Everpure Inc
P
|
+$67.3M |
| 5 |
Roku
ROKU
|
+$53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$212M |
| 2 |
Microsoft
MSFT
|
+$156M |
| 3 |
Amazon
AMZN
|
+$142M |
| 4 |
Honeywell
HON
|
+$119M |
| 5 |
NVIDIA
NVDA
|
+$94.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.1% |
| 2 | Financials | 11.93% |
| 3 | Industrials | 10.35% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Healthcare | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NUTX
2201
Nutex Health
NUTX
$1.51B
| $1.02M | ﹤0.01% |
5,982
+287
| +5% | +$36.4K |
|
2202
Oric Pharmaceuticals
ORIC
$1.36B
| $1.02M | ﹤0.01% |
93,919
+14,856
| +19% | +$135K |
|
2203
Canadian Solar
CSIQ
$733M
| $1.02M | ﹤0.01% |
63,474
+63,309
| +38,369% | +$1.02M |
|
2204
Rigel Pharmaceuticals
RIGL
$900M
| $1.02M | ﹤0.01% |
25,984
+3,292
| +15% | +$102K |
|
|
HTB
2205
HomeTrust Bancshares
HTB
$764M
| $1.01M | ﹤0.01% |
20,265
+1,085
| +6% | +$50.3K |
|
|
PTRN
2206
Pattern Group Inc
PTRN
$3.02B
| $1.01M | ﹤0.01% |
+40,124
| New | +$681K |
|
2207
Stagwell
STGW
$2.03B
| $1M | ﹤0.01% |
135,131
+3,637
| +3% | +$24.1K |
|
2208
First Watch Restaurant Group
FWRG
$626M
| $1M | ﹤0.01% |
77,712
+14,121
| +22% | +$166K |
|
2209
Target Hospitality
TH
$2.02B
| $1M | ﹤0.01% |
49,121
+9,350
| +24% | +$156K |
|
2210
Bloomin' Brands
BLMN
$675M
| $1,000K | ﹤0.01% |
109,408
+4,163
| +4% | +$30.3K |
|
|
CTO
2211
CTO Realty Growth
CTO
$777M
| $994K | ﹤0.01% |
46,219
+2,158
| +5% | +$43.7K |
|
2212
Tronox
TROX
$644M
| $993K | ﹤0.01% |
157,565
-1,528
| -1% | -$13K |
|
2213
Financial Institutions
FISI
$793M
| $991K | ﹤0.01% |
25,431
+274
| +1% | +$9.73K |
|
|
GRDN
2214
Guardian Pharmacy Services
GRDN
$2.61B
| $990K | ﹤0.01% |
23,656
-2,044
| -8% | -$79.1K |
|
2215
Alerus Financial
ALRS
$802M
| $990K | ﹤0.01% |
31,839
+3,106
| +11% | +$85.4K |
|
2216
PAR Technology
PAR
$582M
| $987K | ﹤0.01% |
56,685
+5,728
| +11% | +$82.6K |
|
2217
Dakota Gold
DC
$887M
| $987K | ﹤0.01% |
231,672
+22,318
| +11% | +$120K |
|
2218
Avalo Therapeutics
AVTX
$830M
| $985K | ﹤0.01% |
+53,290
| New | +$842K |
|
2219
Mid Penn Bancorp
MPB
$920M
| $984K | ﹤0.01% |
28,251
+3,376
| +14% | +$112K |
|
2220
MetroCity Bankshares
MCBS
$1.01B
| $981K | ﹤0.01% |
27,345
+2,081
| +8% | +$67.8K |
|
|
SION
2221
Sionna Therapeutics
SION
$236M
| $981K | ﹤0.01% |
22,309
+4,001
| +22% | +$160K |
|
2222
Carter Bankshares
CARE
$702M
| $980K | ﹤0.01% |
28,824
-106
| -0.4% | -$2.87K |
|
2223
LSB Industries
LXU
$712M
| $968K | ﹤0.01% |
89,565
+11,669
| +15% | +$156K |
|
|
ESPR
2224
DELISTED
Esperion Therapeutics
ESPR
| $966K | ﹤0.01% |
305,675
+29,274
| +11% | +$81.9K |
|
|
AVR
2225
Anteris Technologies
AVR
$749M
| $964K | ﹤0.01% |
97,856
+38,673
| +65% | +$294K |
|
Similar funds
RhumbLine Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, RhumbLine Advisers held 4,370 positions worth $133B, up 13% from $117B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2026 filing shows 224 new, 1,883 increased, 1,827 reduced and 182 closed positions. Its largest new stake was Honeywell Aerospace: 529,091 shares worth $117M. The largest sale was Apple, an estimated $212M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- RhumbLine Advisers's largest Q2 2026 buy was Honeywell Aerospace: 529,091 shares worth $117M.
- RhumbLine Advisers added most to Marvell Technology in Q2 2026, an estimated $117M increase.
- RhumbLine Advisers's biggest Q2 2026 reduction was Apple, cutting an estimated $212M.
- RhumbLine Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $53.5M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $133B portfolio in Q2 2026.
- RhumbLine Advisers opened 224 new positions and closed 182 in Q2 2026.
- RhumbLine Advisers's portfolio value rose 13% quarter-over-quarter to $133B.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.